interleukin-1beta (163-171) has been researched along with Delayed Effects, Prenatal Exposure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baud, O; Charriaut-Marlangue, C; Colella, M; Demene, C; Gressens, P; Hassan-Abdi, R; Maccari, S; Mairesse, J; Pansiot, J; Rideau Batista Novais, A; Soussi-Yanicostas, N; Tanter, M; Vaiman, D; Zinni, M | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia.
Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Brain; Brain Injuries; Cells, Cultured; Computational Biology; Diet, Protein-Restricted; Disease Models, Animal; Female; Green Fluorescent Proteins; Interleukin-1beta; Lipopolysaccharides; Microglia; Oxytocics; Oxytocin; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Oxytocin; RNA, Messenger; Zebrafish | 2019 |